16 results
8-K
EX-10.2
PBLA
Panbela Therapeutics, Inc.
29 Jan 24
Panbela Announces Pricing of Approximately $9.0 Million Public Offering
6:21am
approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating
8-K
EX-10.2
PBLA
Panbela Therapeutics, Inc.
21 Jun 23
Panbela Announces Pricing of Approximately $8.5 Million Public Offering
5:00pm
Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales
8-K
EX-10.2
q7yqyw9unnt9q1vjybmf
4 Oct 22
Panbela Announces Pricing of Approximately $6 Million Public Offering
5:26pm
DEFA14A
EX-2.1
zlyyk
22 Feb 22
Additional proxy soliciting materials
8:04am
8-K
EX-2.1
7922 m3qrhd8jazmcf
22 Feb 22
Acquired lead asset will begin a fully-funded registration trial anticipated to start by year-end
8:03am
8-K
EX-1.1
gtlogspry b6x
2 Jul 21
Panbela Therapeutics Announces $5.0 Million Bought Deal Offering of Common Stock
4:06pm
8-K
EX-1.1
zouu1e5bb9nthgu4lztn
1 Sep 20
Sun BioPharma, Inc. Announces Pricing of $10.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:12pm
- Prev
- 1
- Next